Watson Pharmaceuticals, Inc. (NYSE: WPI), announced that it has received a request for additional information from the Federal Trade Commission ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE